Parkinson’s disease

A new super-resolution imaging technique allows researchers to track how surface changes in proteins are related to neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases.

The Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg is coordinating a European Union project for research into new active compounds against Parkinson’s disease (PD).

A funding crisis threatens development of new treatments for mental illness. There needs to be a renewed effort to tackle Europe’s foremost health care challenge – which is currently costing €386 billion per annum